韩国的日本脑炎免疫接种：过去、现在与未来
Japanese encephalitis immunization in South Korea: past, present, and future.
作者信息
Sohn Y M
机构信息
fYonsesi University College of Medcine, Seoul, South Korea.
出版信息
Emerg Infect Dis. 2000 Jan-Feb;6(1):17-24. doi: 10.3201/eid0601.000103.
Abstract
Japanese encephalitis (JE), once a major public health problem in South Korea, has declined since the 1980s, as a result of improved living conditions, a mosquito eradication program, and a national JE vaccination program, which includes annual booster vaccine for all children less than or equal to 15 years of age. Increased immunity has greatly reduced illness and death; however, vaccine adverse effects are increasing, and a National Compensation Program for Vaccine Injury was begun in 1995. This article reviews past successes, current problems, and future direction of the JE vaccination program in South Korea.
摘要
日本脑炎（JE）曾是韩国一个主要的公共卫生问题，自20世纪80年代以来，由于生活条件改善、灭蚊计划以及全国性的日本脑炎疫苗接种计划（包括为所有15岁及以下儿童每年接种加强疫苗），其发病率有所下降。免疫力的提高大大减少了疾病和死亡；然而，疫苗不良反应却在增加，1995年启动了疫苗伤害国家赔偿计划。本文回顾了韩国日本脑炎疫苗接种计划过去的成功经验、当前的问题以及未来的发展方向。
相似文献
1
Japanese encephalitis immunization in South Korea: past, present, and future.韩国的日本脑炎免疫接种：过去、现在与未来
Emerg Infect Dis. 2000 Jan-Feb;6(1):17-24. doi: 10.3201/eid0601.000103.
2
[A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].[流行性乙型脑炎（乙脑）活疫苗（SA14-14-2）在乙脑流行地区的安全性及流行病学效果的大规模研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 1999 Feb;20(1):38-41.
3
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.嵌合型减毒活乙型脑炎疫苗（ChimeriVax-JE）：安全性和免疫原性的2期临床试验、疫苗剂量和接种程序的效果以及对灭活乙型脑炎抗原攻击的记忆反应
J Infect Dis. 2003 Oct 15;188(8):1213-30. doi: 10.1086/378356. Epub 2003 Oct 3.
4
Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.泰国乙型脑炎疫苗接种计划的成本效益分析。
Southeast Asian J Trop Med Public Health. 1997 Mar;28(1):143-8.
5
Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).灭活日本脑炎病毒疫苗。免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 1993 Jan 8;42(RR-1):1-15.
6
Comparative study of protection by Japanese encephalitis (JE) vaccine against a Japanese strain and an Indian strain of JE virus.日本脑炎（JE）疫苗对日本株和印度株日本脑炎病毒保护作用的比较研究。
Indian J Pathol Microbiol. 1976 Oct;19(4):239-43.
7
The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.中国河南乙脑疫苗的效力：一项病例对照研究。
Southeast Asian J Trop Med Public Health. 1994 Dec;25(4):643-6.
8
The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.鼠脑灭活中山株日本脑炎疫苗的效力——台湾30年经验的结果
Vaccine. 2006 Mar 24;24(14):2669-73. doi: 10.1016/j.vaccine.2005.10.054. Epub 2005 Nov 10.
9
Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?儿童接种减毒活日本脑炎疫苗后是否需要加强免疫？
J Trop Pediatr. 2013 Oct;59(5):423-5. doi: 10.1093/tropej/fmt043. Epub 2013 Jun 13.
10
Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.泰国国家免疫计划中鼠脑源性灭活日本脑炎疫苗的有效性：病例对照研究。
Vaccine. 2012 Jan 5;30(2):361-7. doi: 10.1016/j.vaccine.2011.10.083. Epub 2011 Nov 7.
引用本文的文献
1
Mass immunisation to eradicate Japanese encephalitis: Real-world evidence from Guizhou Province in 2005-2021.大规模免疫接种以根除日本脑炎：2005年至2021年贵州省的实际证据。
J Virus Erad. 2024 Mar 24;10(1):100366. doi: 10.1016/j.jve.2024.100366. eCollection 2024 Mar.
2
Japanese Encephalitis among Adults: A Review.成人日本脑炎：综述。
Am J Trop Med Hyg. 2023 Apr 10;108(5):860-864. doi: 10.4269/ajtmh.23-0036. Print 2023 May 3.
3
Evaluation of dogs () as an indicator of Japanese encephalitis (JE) outbreaks: A retrospective serological study in the Seoul metropolitan area around the 2010 resurgence of JE in the Republic of Korea.将犬类作为日本脑炎（JE）疫情指标的评估：韩国首尔大都市区围绕2010年日本脑炎疫情复苏的一项回顾性血清学研究。
One Health. 2022 Nov 17;15:100459. doi: 10.1016/j.onehlt.2022.100459. eCollection 2022 Dec.
4
Seroepidemiological study of Japanese encephalitis virus in Chiang Mai: Immunity and susceptibility 28 years after introduction of a vaccination programme.清迈日本脑炎病毒的血清流行病学研究：接种疫苗 28 年后的免疫和易感性。
PLoS Negl Trop Dis. 2022 Aug 1;16(8):e0010674. doi: 10.1371/journal.pntd.0010674. eCollection 2022 Aug.
5
Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea.韩国日本脑炎病毒特定年龄血清阳性率的变化及日本脑炎疫苗的影响。
Clin Exp Pediatr. 2022 Mar;65(3):108-114. doi: 10.3345/cep.2020.01984. Epub 2021 Sep 24.
6
Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.SA 14-14-2 减毒活日本脑炎疫苗在缅甸的有效性。
Vaccines (Basel). 2021 May 31;9(6):568. doi: 10.3390/vaccines9060568.
7
Seroprevalence of Neutralizing Antibodies against Japanese Encephalitis Virus among Adolescents and Adults in Korea: A Prospective Multicenter Study.韩国青少年和成年人中抗日本脑炎病毒中和抗体的血清流行率：一项前瞻性多中心研究
Vaccines (Basel). 2020 Jun 19;8(2):328. doi: 10.3390/vaccines8020328.
8
Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.中国云南省将乙型脑炎疫苗纳入长期扩大免疫规划后发病率的变化模式。
Infect Dis Poverty. 2019 Dec 10;8(1):102. doi: 10.1186/s40249-019-0608-7.
9
Co-infection of and Japanese encephalitis virus in a spotted seal () in the Republic of Korea.韩国一只斑海豹体内 与日本脑炎病毒的共感染。 （原文中“Co-infection of and”这里少了具体内容）
J Vet Sci. 2019 Nov;20(6):e65. doi: 10.4142/jvs.2019.20.e65.
10
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.日本脑炎疫苗：免疫实践咨询委员会的建议。
MMWR Recomm Rep. 2019 Jul 19;68(2):1-33. doi: 10.15585/mmwr.rr6802a1.
本文引用的文献
1
Status and significance of inapparent infection with virus of Japanese B encephalitis in Korea and Okinawa in 1946.1946年韩国和冲绳地区日本乙型脑炎病毒隐性感染的现状及意义
Am J Hyg. 1950 Jan;51(1):13-20. doi: 10.1093/oxfordjournals.aje.a119374.
Zotero 插件